| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2433* | 2021 |
| The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity MG Seidel, G Kindle, B Gathmann, I Quinti, M Buckland, J van Montfrans, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 1763-1770, 2019 | 503 | 2019 |
| Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase δ syndrome: the european society for immunodeficiencies-activated phosphoinositide 3-kinase δ … ME Maccari, H Abolhassani, A Aghamohammadi, A Aiuti, O Aleinikova, ... Frontiers in immunology 9, 543, 2018 | 303 | 2018 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 252 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 251 | 2022 |
| Whole-genome sequencing of a sporadic primary immunodeficiency cohort JED Thaventhiran, H Lango Allen, OS Burren, W Rae, D Greene, ... Nature 583 (7814), 90-95, 2020 | 191 | 2020 |
| British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic … JR Hurst, N Verma, D Lowe, HE Baxendale, S Jolles, P Kelleher, ... The Journal of Allergy and Clinical Immunology: In Practice 5 (4), 938-945, 2017 | 175 | 2017 |
| Chronic fatigue syndrome and circulating cytokines: a systematic review S Blundell, KK Ray, M Buckland, PD White Brain, behavior, and immunity 50, 186-195, 2015 | 168 | 2015 |
| Hypogammaglobulinaemia after rituximab treatment—incidence and outcomes M Makatsori, S Kiani-Alikhan, AL Manson, N Verma, M Leandro, ... QJM: An International Journal of Medicine 107 (10), 821-828, 2014 | 153 | 2014 |
| The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008–2012 JDM Edgar, M Buckland, D Guzman, NP Conlon, V Knerr, C Bangs, ... Clinical & Experimental Immunology 175 (1), 68-78, 2014 | 116 | 2014 |
| Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, ... Nature communications 11 (1), 6385, 2020 | 112 | 2020 |
| Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations T Lorenzini, M Fliegauf, N Klammer, N Frede, M Proietti, A Bulashevska, ... Journal of Allergy and Clinical Immunology 146 (4), 901-911, 2020 | 107 | 2020 |
| Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ... Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021 | 101 | 2021 |
| The United Kingdom primary immune deficiency (UKPID) registry 2012 to 2017 B Shillitoe, C Bangs, D Guzman, AR Gennery, HJ Longhurst, M Slatter, ... Clinical & Experimental Immunology 192 (3), 284-291, 2018 | 101 | 2018 |
| Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities C van Kooten, G Lombardi, KA Gelderman, P Sagoo, M Buckland, ... Transplantation 91 (1), 2-7, 2011 | 98 | 2011 |
| Long-term persistence of spike protein antibody and predictive modeling of antibody dynamics after infection with severe acute respiratory syndrome coronavirus 2 L Grandjean, A Saso, A Torres Ortiz, T Lam, J Hatcher, R Thistlethwayte, ... Clinical Infectious Diseases 74 (7), 1220-1229, 2022 | 94* | 2022 |
| Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement SS Duraisingham, M Buckland, J Dempster, L Lorenzo, S Grigoriadou, ... Plos one 9 (6), e100324, 2014 | 90 | 2014 |
| Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency TA Fox, R Chakraverty, S Burns, B Carpenter, K Thomson, D Lowe, ... Blood, The Journal of the American Society of Hematology 131 (8), 917-931, 2018 | 80 | 2018 |
| Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies IK Na, M Buckland, C Agostini, JDM Edgar, V Friman, M Michallet, ... European journal of haematology 102 (6), 447-456, 2019 | 78 | 2019 |
| Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells M Buckland, CB Jago, H Fazekasova, K Scott, PH Tan, AJT George, ... American journal of transplantation 6 (9), 2046-2059, 2006 | 75 | 2006 |
